CYP3A22稳定表达HepG<sub>2</sub>细胞株的建立及其探针药物代谢活性鉴定

薛正楷; 魏泓; 商海涛; 杨根庆; 叶彬

您当前的位置：

首页 >

文章列表页 >

CYP3A22稳定表达HepG₂细胞株的建立及其探针药物代谢活性鉴定

论著 | 更新时间：2026-01-09

- CYP3A22稳定表达HepG₂细胞株的建立及其探针药物代谢活性鉴定
- Establishment of a HepG₂ cell line stably expressing CYP3A22 and identification of the metabolic activity of the probe drugs
- 陆军军医大学学报 2009年31卷第16期页码：1552-1555
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R322.47;R394-33;R394.6
- 纸质出版：2009
- 稿件说明：
移动端阅览
薛正楷,魏泓,商海涛,杨根庆,叶彬.CYP3A22稳定表达HepG2细胞株的建立及其探针药物代谢活性鉴定[J].陆军军医大学学报(原第三军医大学学报),2009,31(16):1552-1555.

　XUE Zheng-kai,WEI Hong,SHANG Hai-tao,YANG Gen-qing,YE Bin.Establishment of a HepG2 cell line stably expressing CYP3A22 and identification of the metabolic activity of the probe drugs[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(16):1552-1555.
薛正楷,魏泓,商海涛,杨根庆,叶彬.CYP3A22稳定表达HepG2细胞株的建立及其探针药物代谢活性鉴定[J].陆军军医大学学报(原第三军医大学学报),2009,31(16):1552-1555. DOI：

　XUE Zheng-kai,WEI Hong,SHANG Hai-tao,YANG Gen-qing,YE Bin.Establishment of a HepG2 cell line stably expressing CYP3A22 and identification of the metabolic activity of the probe drugs[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(16):1552-1555. DOI：

摘要

目的建立稳定表达Bama小型猪细胞色素CYP3A22的HepG

细胞株。方法通过从Bama小型猪肝组织中提取tRNA、经RT-PCR得到Bama小型猪CYP3A22的基因，并将此基因克隆至亚克隆载体pMD18-T上得到重组质粒pMD-3A22；以测序确定的重组质粒pMD-3A22为模板，采用PCR扩增CYP3A22基因并在其3′添加组氨酸标签，扩增产物经BamHⅠ/ XhoⅠ双酶切，将带有组氨酸标签的CYP3A22基因定向克隆至pcDNA3.1（+）中，测序表明，CYP3A22基因真核表达载体正确构建;将测序正确的CYP3A22基因通过脂质体转染至HepG

细胞，G418筛选10代，RT-PCR及Western blot分析，并用探针药物硝苯地平对重组细胞进行进行活性鉴定。结果与HepG

相比，HepG

-CYP3A22细胞株具有极显著的硝苯地平氧化活性。结论成功建立了稳定表达CYP3A22的HepG

细胞株，可用于相关的药物代谢研究。

Abstract

Objective To establish a HepG

cell line

which can stably express Sus scrofa CYP3A22

for the evaluation of the drug metabolic characteristics of CYP3A22. Methods Sus scrofa CYP3A22 gene obtained by PCR was cloned into the eukaryotic expression vector pcDNA3.1 [The tissue of Bama minipig was amplified by RT-PCR. The gene was subcloned into plasmid pMD18-T (designated as pMD-3A22)

and then the gene amplified by recombinant plasmid was designated as pcDNA-3A22

]

. Then Sus scrofa CYP3A22 gene was

confirmed by sequencing. Next

the confirmed gene was transfected into HepG

cells by lipid-media transfection

and the transformant HepG

cells were screened by G418 for 10 generations. Expression of CYP3A22 in HepG

cells was identified by RT-PCR and Western blot analyses

and the metabolic activity of transformant HepG

(HepG

-CYP3A22) was verified by nifedipine oxidation. Results The HepG

-CYP3A22 line demonstrated a significantly higher oxidative activity as compared with the negative control HepG

line. Conclusion HepG

cell line stably expressing CYP3A22 was established successfully. The cell line may be useful for the studies of toxicity and pharmacology.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

pE₆/p53/GFP重组真核表达载体的构建及其对肺腺癌细胞周期的影响

难治性颞叶癫痫患者颞叶皮层金属基质蛋白酶-9的表达

CLIC-1 mRNA及蛋白在结肠癌的表达及临床意义

上调基因-4在结肠癌中的表达及临床意义

大熊猫核糖体蛋白L10亚基基因的cDNA克隆及序列分析

CYP3A22稳定表达HepG2细胞株的建立及其探针药物代谢活性鉴定

Establishment of a HepG2 cell line stably expressing CYP3A22 and identification of the metabolic activity of the probe drugs

DOI：

摘要

Abstract

关键词

Keywords

references

CYP3A22稳定表达HepG₂细胞株的建立及其探针药物代谢活性鉴定

Establishment of a HepG₂ cell line stably expressing CYP3A22 and identification of the metabolic activity of the probe drugs